HOSMAC, a renowned healthcare design and consulting firm, has successfully designed Cipla’s Breathefree Lung Wellness Centre in Mumbai. The centre is a testament to HOSMAC’s expertise in creating healthcare facilities that prioritize patient-centric care and wellness. The design of the centre emphasizes adaptive reuse, transforming an existing building into a state-of-the-art lung wellness centre.<\/p>\n
The Breathefree Lung Wellness Centre is a 5,000-square-foot facility located in the heart of Mumbai. The centre offers a comprehensive range of services, including lung function testing, pulmonary rehabilitation, and patient education. The design of the centre is centered around the concept of “wellness-led care,” which focuses on promoting overall well-being and preventive care rather than just treating illnesses.<\/p>\n
HOSMAC’s design team worked closely with Cipla to create a space that is both functional and aesthetically appealing. The centre features a modern and sleek design, with ample natural light and ventilation. The interior design elements, including the color scheme and furniture, are carefully selected to create a calming and soothing atmosphere, conducive to patient recovery and wellness.<\/p>\n
One of the key highlights of the centre is its emphasis on adaptive reuse. The existing building was transformed into a lung wellness centre, minimizing waste and reducing the environmental impact of the project. The design team worked closely with the existing structure, incorporating sustainable design principles and materials to create a energy-efficient and eco-friendly facility.<\/p>\n
The Breathefree Lung Wellness Centre is equipped with cutting-edge technology and medical equipment, ensuring that patients receive the best possible care. The centre also features a team of experienced healthcare professionals, including pulmonologists, physiotherapists, and nutritionists, who work together to provide comprehensive care to patients.<\/p>\n
The centre’s design and services are tailored to meet the specific needs of patients with lung diseases, such as chronic obstructive pulmonary disease (COPD) and asthma. The centre offers a range of programs and services, including pulmonary rehabilitation, smoking cessation, and patient education, to help patients manage their condition and improve their overall quality of life.<\/p>\n
Overall, the Breathefree Lung Wellness Centre is a shining example of HOSMAC’s expertise in designing healthcare facilities that prioritize patient-centric care and wellness. The centre’s emphasis on adaptive reuse, wellness-led care, and sustainable design principles makes it a unique and innovative healthcare facility in Mumbai. With its state-of-the-art technology, experienced healthcare professionals, and comprehensive range of services, the centre is poised to become a leading destination for lung wellness and care in the region.<\/p>\n","protected":false},"excerpt":{"rendered":"
HOSMAC, a renowned healthcare design and consulting firm, has successfully designed Cipla’s Breathefree Lung Wellness Centre in Mumbai. The centre is a testament to HOSMAC’s expertise in creating healthcare facilities that prioritize patient-centric care and wellness. The design of the centre emphasizes adaptive reuse, transforming an existing building into a state-of-the-art lung wellness centre. The […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[17,2],"tags":[],"class_list":["post-89888","post","type-post","status-publish","format-standard","hentry","category-cipla","category-pharma"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89867,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/27\/indias-path-to-universal-health-care-outlined-in-lancet-paper-ahead-of-budget-2026-bw-healthcare-world\/","url_meta":{"origin":89888,"position":0},"title":"India’s Path To Universal Health Care Outlined In Lancet Paper Ahead Of Budget 2026 – BW Healthcare World","author":"Team Small News","date":"January 27, 2026","format":false,"excerpt":"A recent paper published in The Lancet has outlined a roadmap for India to achieve universal health care by 2030, with a focus on the upcoming Budget 2026. The paper, titled \"India's path to universal health coverage: a call to action,\" highlights the country's progress towards achieving universal health care\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89869,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/27\/zydus-lifesciences-introduces-indias-first-biosimilar-version-of-nivolumab-a-global-breakthrough\/","url_meta":{"origin":89888,"position":1},"title":"Zydus Lifesciences introduces India’s first biosimilar version of Nivolumab, a global breakthrough.","author":"Team Small News","date":"January 27, 2026","format":false,"excerpt":"Zydus Lifesciences, a leading life sciences company, has launched the world's first biosimilar of nivolumab in India under the brand name Tishtha. This milestone marks a significant expansion of patient access to cutting-edge cancer therapies, particularly in the field of Immuno-Oncology. Tishtha will be available in two dosage strengths, 100\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":89854,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/25\/bengaluru-to-host-zydus-pinkathon-after-a-7-year-hiatus\/","url_meta":{"origin":89888,"position":2},"title":"Bengaluru to host Zydus Pinkathon after a 7-year hiatus","author":"Team Small News","date":"January 25, 2026","format":false,"excerpt":"The Zydus Pinkathon, a prominent women's running event, is set to return to Bengaluru on January 25, marking its eighth edition in the city after a seven-year hiatus. With an expected participation of over 5,000 women, the event aims to promote fitness and community engagement among women of all age\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":89876,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/29\/hyderabad-to-witness-global-voices-one-vision-international-health-dialogue-2026-hosted-by-apollo-hospitals\/","url_meta":{"origin":89888,"position":3},"title":"Hyderabad to Witness ‘Global Voices, One Vision’ International Health Dialogue 2026, Hosted by Apollo Hospitals","author":"Team Small News","date":"January 29, 2026","format":false,"excerpt":"The 13th edition of the International Health Dialogue (IHD) will be hosted by Apollo Hospitals in Hyderabad on January 30 and 31, 2026. The event will bring together global leaders to discuss patient safety, healthcare innovation, and system-wide transformation. The theme of IHD 2026, \"Global Voices. One Vision,\" emphasizes the\u2026","rel":"","context":"In "Apollo Hospital"","block_context":{"text":"Apollo Hospital","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/apollo-hospital\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89753,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/05\/national-pharmaceutical-pricing-authority-caps-retail-price-of-sun-pharmas-gemcitabine-injections\/","url_meta":{"origin":89888,"position":4},"title":"National Pharmaceutical Pricing Authority Caps Retail Price of Sun Pharma’s Gemcitabine Injections","author":"Team Small News","date":"January 5, 2026","format":false,"excerpt":"The National Pharmaceutical Pricing Authority (NPPA) has set the retail price for Sun Pharma's Gemcitabine injections. Gemcitabine is a chemotherapy medication used to treat various types of cancer, including pancreatic, breast, ovarian, and non-small cell lung cancer. The NPPA, which is responsible for regulating the prices of pharmaceutical products in\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":89795,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/13\/the-delhi-high-court-has-granted-permission-to-zydus-to-market-a-more-affordable-biosimilar-version-of-the-cancer-medication-nivolumab-citing-public-interest\/","url_meta":{"origin":89888,"position":5},"title":"The Delhi High Court has granted permission to Zydus to market a more affordable biosimilar version of the cancer medication Nivolumab, citing public interest.","author":"Team Small News","date":"January 13, 2026","format":false,"excerpt":"The Delhi High Court has given a significant ruling in favor of Zydus, a pharmaceutical company, allowing it to sell a biosimilar version of the cancer drug Nivolumab at a lower price. Nivolumab, marketed under the brand name Opdivo by Bristol Myers Squibb, is a monoclonal antibody used to treat\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89888"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89888\/revisions"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89888"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89888"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}